BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6112753)

  • 21. [Effects of somatostatin and its analogue, des (Ala1, Gly2) [D-Trp8, D-Asu3,14]-somatostatin (SS-1), on gastric mucosal blood flow and gastric secretion].
    Nishimura T; Sakonjo H; Nakanishi J; Ikeda H; Nomura M; Nishimori T
    Nihon Yakurigaku Zasshi; 1986 May; 87(5):551-6. PubMed ID: 2874104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the gastric exocrine inhibitory activities and plasma kinetics of somatostatin-28 and somatostatin-14 in cats.
    Hirst BH; Conlon JM; Coy DH; Holland J; Shaw B
    Regul Pept; 1982 Sep; 4(4):227-37. PubMed ID: 6128770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Valosin stimulates gastric and exocrine pancreatic secretion and inhibits fasting small intestinal myoelectric activity in the dog.
    Konturek SJ; Schmidt WE; Mutt V; Konturek JW; Creutzfeldt W
    Gastroenterology; 1987 May; 92(5 Pt 1):1181-6. PubMed ID: 3104127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Somatostatin and gastrointestinal secretion and motility.
    Konturek SJ
    Adv Exp Med Biol; 1978; 106():227-34. PubMed ID: 717163
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of intestinal hormones on splanchnic circulation.
    Benyó I; Szabó G
    Res Exp Med (Berl); 1978 Sep; 173(3):301-6. PubMed ID: 725331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition by somatostatin (growth-hormone release-inhibiting hormone, GH-RIH) of gastric acid and pepsin and G-cell release of gastrin.
    Barros D'sa AA; Bloom SR; Baron JH
    Gut; 1978 Apr; 19(4):315-20. PubMed ID: 348581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of the inhibitory action of endogenous cholecystokinin and caerulein on pentagastrin--induced gastric secretion.
    Konturek SJ; Tasler J; Obtulowicz W
    Scand J Gastroenterol; 1972; 7(7):657-62. PubMed ID: 4640057
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of somatostatin-14 and somatostatin-28 on plasma hormonal and gastric secretory responses to cephalic and gastrointestinal stimulation in man.
    Konturek SJ; Kwiecień N; Obtułowicz W; Bielański W; Oleksy J; Schally AV
    Scand J Gastroenterol; 1985 Jan; 20(1):31-8. PubMed ID: 2859650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of substance P and its C-terminal hexapeptide on gastric and pancreatic secretion in the dog.
    Konturek SJ; Jaworek J; Tasler J; Cieszkowski M; Pawlik W
    Am J Physiol; 1981 Jul; 241(1):G74-81. PubMed ID: 6166208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MEK inhibits secretin release and pancreatic secretion: roles of secretin-releasing peptide and somatostatin.
    Li JP; Lee KY; Chang TM; Chey WY
    Am J Physiol Gastrointest Liver Physiol; 2001 May; 280(5):G890-6. PubMed ID: 11292597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of growth hormone release-inhibiting hormone on gastric secretion, mucosal blood flow, and serum gastrin.
    Konturek SJ; Tasler J; Cieszkowski M; Coy DH; Schally AV
    Gastroenterology; 1976 May; 70(5 PT.1):737-41. PubMed ID: 1261766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition by secretin of the gastric acid responses to meals and to pentagastrin in duodenal ulcer patients.
    Konturek SJ; Biernat J; Grzelec T
    Gut; 1973 Nov; 14(11):842-6. PubMed ID: 4761603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of somatostatin on intestinal circulation and oxygen consumption.
    Pawlik WW; Gustaw P; Czarnobilski K; Sendur R; Konturek SJ
    Acta Physiol Hung; 1989; 74(3-4):277-83. PubMed ID: 2576989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastric inhibitory polypeptide (GIP) is not the primary mediator of the enterogastrone action of fat in the dog.
    Yamagishi T; Debas HT
    Gastroenterology; 1980 May; 78(5 Pt 1):931-6. PubMed ID: 6445850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of exocrine pancreatic secretion by somatostatin in dogs.
    Susini C; Esteve JP; Bommelaer G; Vaysse N; Ribet A
    Digestion; 1978; 18(5-6):384-93. PubMed ID: 750262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Gastrointestinal hormones and blood circulation in the gastric mucosa].
    Koch H
    Z Gastroenterol; 1976 Mar; 14 Suppl():105-9. PubMed ID: 960910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of gastric and pancreatic secretion in dogs by CGRP: role of somatostatin.
    Helton WS; Mulholland MM; Bunnett NW; Debas HT
    Am J Physiol; 1989 Apr; 256(4 Pt 1):G715-20. PubMed ID: 2565089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of epidermal growth factor on gastrointestinal secretions.
    Konturek SJ; Cieszkowski M; Jaworek J; Konturek J; Brzozowski T; Gregory H
    Am J Physiol; 1984 May; 246(5 Pt 1):G580-6. PubMed ID: 6326613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics of intestinal phase of gastric secretion.
    Konturek SJ; Kaess H; Kwiecień N; Radecki T; Dorner M; Teckentrupp U
    Am J Physiol; 1976 Feb; 230(2):335-40. PubMed ID: 3974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of somatostatin on pentagastrin-stimulated gastric acid secretion and gastric antral motility in dogs with gastric fistula.
    Bech K; Andersen D
    Scand J Gastroenterol; 1984 Sep; 19(6):740-6. PubMed ID: 6151241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.